Bioelectronics Corp (BIEL)

[DewmBoom]

what if they don't license and get FDA approval for OTC. 120 million people in the US may have a need for an Actipatch once a year. I am going to be conservative and assume 25% of hem buy one at most in one year. At a price of $30, that is 900 mil in revenue. Even at 50% discount, that is 450 mil from the US only. However, bare in mind if the US approves it for OTC, that is a green ticket worldwide. That is why this is s big deal. If OTC approval is granted, then exponential growth is to be expected.

Actipatch Growth Beyond Imagination